David Amsellem

Mr. David Amsellem is a Senior Research Analyst at Piper Sandler & Co. He is also working as Managing Director.
He covers Biotechnology.
Prior to joining Piper Sandler in 2008, Mr. Amsellem spent five years at Friedman Billings Ramsey, where he was a senior research analyst covering small- and mid-cap pharmaceuticals from 2006-08 and a senior associate on the biotechnology equity research team from 2003-06.
He has over 20 Years of Wall Street experience focused on the biopharmaceuticals space, with experience in life sciences investment and merchant banking prior to moving to the sell-side.
Mr. Amsellem earned a bachelor's degree from Cornell University.